PT81498B
(pt)
*
|
1984-11-23 |
1987-12-30 |
Schering Ag |
Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
|
US5597531A
(en)
*
|
1985-10-04 |
1997-01-28 |
Immunivest Corporation |
Resuspendable coated magnetic particles and stable magnetic particle suspensions
|
US4795698A
(en)
*
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
US5512332A
(en)
*
|
1985-10-04 |
1996-04-30 |
Immunivest Corporation |
Process of making resuspendable coated magnetic particles
|
US5160726A
(en)
*
|
1990-02-15 |
1992-11-03 |
Advanced Magnetics Inc. |
Filter sterilization for production of colloidal, superparamagnetic MR contrast agents
|
US5262176A
(en)
*
|
1986-07-03 |
1993-11-16 |
Advanced Magnetics, Inc. |
Synthesis of polysaccharide covered superparamagnetic oxide colloids
|
US5102652A
(en)
*
|
1986-07-03 |
1992-04-07 |
Advanced Magnetics Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
US4951675A
(en)
*
|
1986-07-03 |
1990-08-28 |
Advanced Magnetics, Incorporated |
Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
|
US5248492A
(en)
*
|
1986-07-03 |
1993-09-28 |
Advanced Magnetics, Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
US5219554A
(en)
|
1986-07-03 |
1993-06-15 |
Advanced Magnetics, Inc. |
Hydrated biodegradable superparamagnetic metal oxides
|
DE3709851A1
(de)
*
|
1987-03-24 |
1988-10-06 |
Silica Gel Gmbh Adsorptions Te |
Nmr-diagnostische fluessigkeitszusammensetzungen
|
US5395688A
(en)
*
|
1987-10-26 |
1995-03-07 |
Baxter Diagnostics Inc. |
Magnetically responsive fluorescent polymer particles
|
US6013531A
(en)
*
|
1987-10-26 |
2000-01-11 |
Dade International Inc. |
Method to use fluorescent magnetic polymer particles as markers in an immunoassay
|
WO1989004373A1
(en)
*
|
1987-10-26 |
1989-05-18 |
Baxter International Inc. |
Process for producing magnetically responsive polymer particles and application thereof
|
DE3807904A1
(de)
*
|
1988-03-10 |
1989-09-21 |
Behringwerke Ag |
Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
|
US5238811A
(en)
*
|
1988-04-26 |
1993-08-24 |
Nippon Telegraph And Telephone Corporation |
Laser magnetic immunoassay method and apparatus therefor and superparamagnetic material-labeled body and method for the manufacture of same
|
DE68911359T2
(de)
*
|
1988-04-26 |
1994-05-11 |
Nippon Telegraph & Telephone |
Lasermagnetisches Immuntestverfahren und Gerät dazu.
|
US5236824A
(en)
*
|
1988-04-26 |
1993-08-17 |
Nippon Telegraph And Telephone Corporation |
Laser magnetic immunoassay method and method by a magnetophoresis apparatus therefor
|
GB8813682D0
(en)
*
|
1988-06-09 |
1988-07-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
US5145661A
(en)
*
|
1988-08-31 |
1992-09-08 |
Wayne State University |
Method and contrast agent for use in magnetic resonance imaging of abscess
|
US5108933A
(en)
*
|
1988-09-16 |
1992-04-28 |
Immunicon Corporation |
Manipulation of colloids for facilitating magnetic separations
|
IE71197B1
(en)
*
|
1988-11-14 |
1997-02-12 |
Akzo Nv |
Aqueous suspension for diagnostic tests
|
JPH02210262A
(ja)
*
|
1989-02-10 |
1990-08-21 |
Shinotesuto Kenkyusho:Kk |
間接凝集反応測定法
|
US5114703A
(en)
*
|
1989-05-30 |
1992-05-19 |
Alliance Pharmaceutical Corp. |
Percutaneous lymphography using particulate fluorocarbon emulsions
|
DE3919873A1
(de)
*
|
1989-06-19 |
1990-12-20 |
Behringwerke Ag |
Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
|
US5178834A
(en)
*
|
1989-07-19 |
1993-01-12 |
Tosoh Corporation |
Automatic immunoassay analyzer
|
US5698271A
(en)
*
|
1989-08-22 |
1997-12-16 |
Immunivest Corporation |
Methods for the manufacture of magnetically responsive particles
|
FR2656317B1
(fr)
*
|
1989-12-27 |
1994-02-04 |
Rhone Poulenc Chimie |
Microspheres magnetisables a base de polysilsesquioxane, leur procede de preparation et leur application en biologie.
|
FR2656318B1
(fr)
*
|
1989-12-27 |
1994-02-04 |
Rhone Poulenc Chimie |
Microspheres "core-shell" magnetisables a base d'organopolysiloxane reticule, leur procede de preparation et leur application en biologie.
|
WO1991012025A1
(en)
|
1990-02-15 |
1991-08-22 |
Advanced Magnetics Inc. |
Filter sterilization for production of colloidal, superparamagnetic mr contrast agents
|
GB9006977D0
(en)
*
|
1990-03-28 |
1990-05-23 |
Nycomed As |
Compositions
|
US5164297A
(en)
*
|
1990-05-03 |
1992-11-17 |
Advanced Magnetics Inc. |
Solvent mediated relaxation assay system
|
US5254460A
(en)
*
|
1990-05-03 |
1993-10-19 |
Advanced Magnetics, Inc. |
Solvent mediated relaxation assay system
|
US5240640A
(en)
*
|
1990-06-04 |
1993-08-31 |
Coulter Corporation |
In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles
|
IL98744A0
(en)
*
|
1990-07-06 |
1992-07-15 |
Gen Hospital Corp |
Method of studying biological tissue using monocrystalline particles
|
US5622831A
(en)
*
|
1990-09-26 |
1997-04-22 |
Immunivest Corporation |
Methods and devices for manipulation of magnetically collected material
|
US6013532A
(en)
*
|
1990-09-26 |
2000-01-11 |
Immunivest Corporation |
Methods for magnetic immobilization and manipulation of cells
|
US5200084A
(en)
*
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
US5466609A
(en)
*
|
1990-10-31 |
1995-11-14 |
Coulter Corporation |
Biodegradable gelatin-aminodextran particle coatings of and processes for making same
|
US5169754A
(en)
*
|
1990-10-31 |
1992-12-08 |
Coulter Corporation |
Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
|
US5639620A
(en)
*
|
1990-10-31 |
1997-06-17 |
Coulter Corporation |
Polymeric particles having a biodegradable gelatin or aminodextran coating and process for making same
|
WO1992012735A1
(en)
*
|
1991-01-19 |
1992-08-06 |
Meito Sangyo Kabushiki Kaisha |
Composition containing ultrafine particles of magnetic metal oxide
|
US5370901A
(en)
*
|
1991-02-15 |
1994-12-06 |
Bracco International B.V. |
Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
|
US5242833A
(en)
*
|
1991-03-20 |
1993-09-07 |
Reference Diagnostics, Inc. |
Lipid fractionation
|
US5466574A
(en)
*
|
1991-03-25 |
1995-11-14 |
Immunivest Corporation |
Apparatus and methods for magnetic separation featuring external magnetic means
|
US5186827A
(en)
*
|
1991-03-25 |
1993-02-16 |
Immunicon Corporation |
Apparatus for magnetic separation featuring external magnetic means
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5646001A
(en)
*
|
1991-03-25 |
1997-07-08 |
Immunivest Corporation |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
|
JPH06506449A
(ja)
*
|
1991-03-27 |
1994-07-21 |
サルター アイエヌシー |
コントラスト媒体
|
CA2065719A1
(en)
|
1991-04-30 |
1992-10-31 |
John B. Findlay |
Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle
|
IT1252145B
(it)
*
|
1991-11-29 |
1995-06-05 |
Bracco Ind Chimica Spa |
Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
|
US5225282A
(en)
*
|
1991-12-13 |
1993-07-06 |
Molecular Bioquest, Inc. |
Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer
|
US5248772A
(en)
*
|
1992-01-29 |
1993-09-28 |
Coulter Corporation |
Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
|
GB2265004B
(en)
*
|
1992-03-10 |
1996-01-10 |
Univ Cardiff |
Immuno-agglutination assay using ultrasonic standing wave field
|
US5334471A
(en)
*
|
1992-07-02 |
1994-08-02 |
Xerox Corporation |
Low gloss encapsulated compositions
|
AU5360394A
(en)
*
|
1992-10-15 |
1994-05-09 |
Coulter Corporation |
Particles having gelatin-aminodextran coatings of and processes for making same
|
US5349957A
(en)
*
|
1992-12-02 |
1994-09-27 |
Sterling Winthrop Inc. |
Preparation and magnetic properties of very small magnetite-dextran particles
|
US5855790A
(en)
*
|
1994-02-07 |
1999-01-05 |
Selective Environmental Technologies, Inc. |
Magnetic particles, a method for the preparation thereof and their use in the purification of solutions
|
DE69507482T2
(de)
*
|
1994-07-07 |
1999-08-19 |
Chiron Diagnostics Corp |
Hochdispergierte magnetische metalloxidteilchen,produktionsverfahren und anwendung
|
US5871625A
(en)
|
1994-08-25 |
1999-02-16 |
University Of Iowa Research Foundation |
Magnetic composites for improved electrolysis
|
US6001248A
(en)
*
|
1994-08-25 |
1999-12-14 |
The University Of Iowa Research Foundation |
Gradient interface magnetic composites and systems therefor
|
US5622822A
(en)
|
1994-09-13 |
1997-04-22 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Methods for capture and selective release of nucleic acids using polyethyleneimine and an anionic phosphate ester surfactant and amplification of same
|
US5705366A
(en)
*
|
1994-09-15 |
1998-01-06 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
|
US5582988A
(en)
|
1994-09-15 |
1996-12-10 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same
|
US5693784A
(en)
*
|
1994-09-19 |
1997-12-02 |
Promega Corporation |
Methods for creating agglomerates from colloidal particles
|
US5750339A
(en)
*
|
1994-11-30 |
1998-05-12 |
Thomas Jefferson University |
Methods for identifying fetal cells
|
EP0873358A2
(de)
*
|
1995-01-13 |
1998-10-28 |
Innogenetics N.V. |
Einfangen von mikroorganismen mittels komplement komponenten
|
US5705059A
(en)
*
|
1995-02-27 |
1998-01-06 |
Miltenyi; Stefan |
Magnetic separation apparatus
|
US5741714A
(en)
*
|
1995-07-18 |
1998-04-21 |
Immunivest Corporation |
Detection of bound analyte by magnetic partitioning and masking
|
US5660990A
(en)
*
|
1995-08-18 |
1997-08-26 |
Immunivest Corporation |
Surface immobilization of magnetically collected materials
|
CN1212629A
(zh)
|
1996-01-10 |
1999-03-31 |
耐克麦德英梅金公司 |
造影剂
|
GB9600427D0
(en)
*
|
1996-01-10 |
1996-03-13 |
Nycomed Imaging As |
Contrast media
|
DE19606598C1
(de)
*
|
1996-02-22 |
1997-11-13 |
Innova Gmbh |
Magnetpartikel mit biologisch aktiven Rezeptoren sowie Herstellung und Verwendung
|
DE69737883T2
(de)
|
1996-04-25 |
2008-03-06 |
Bioarray Solutions Ltd. |
Licht-regulierte, elektrokinetische zusammensetzung von partikeln an oberflächen
|
FR2758884B1
(fr)
|
1997-01-30 |
1999-04-02 |
Bio Merieux |
Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu
|
FR2762394B1
(fr)
*
|
1997-04-16 |
1999-05-28 |
Bio Merieux |
Compose ligand de coordination et utilisation pour fixer un materiel biologique
|
JP2002511141A
(ja)
|
1997-06-18 |
2002-04-09 |
イノーファ・ゲゼルシャフト・ツーァ・エントヴィックルング・ウント・フェアマルクトゥング・イノファティファー・プロドゥクテ・エムベーハー |
生物学的活性レセプターを有する磁性粒子
|
US6241894B1
(en)
*
|
1997-10-10 |
2001-06-05 |
Systemix |
High gradient magnetic device and method for cell separation or purification
|
US6337215B1
(en)
|
1997-12-01 |
2002-01-08 |
International Business Machines Corporation |
Magnetic particles having two antiparallel ferromagnetic layers and attached affinity recognition molecules
|
US7282350B2
(en)
|
1998-02-12 |
2007-10-16 |
Immunivest Corporation |
Labeled cell sets for use as functional controls in rare cell detection assays
|
JP2002503814A
(ja)
*
|
1998-02-12 |
2002-02-05 |
イムニベスト・コーポレイション |
循環ガン細胞の迅速かつ効率的な単離のための方法および試薬
|
US20010018192A1
(en)
*
|
1998-02-12 |
2001-08-30 |
Terstappen Leon W.M.M. |
Labeled cells for use as an internal functional control in rare cell detection assays
|
US6908770B1
(en)
*
|
1998-07-16 |
2005-06-21 |
Board Of Regents, The University Of Texas System |
Fluid based analysis of multiple analytes by a sensor array
|
US6368866B1
(en)
|
1998-08-03 |
2002-04-09 |
Reference Diagnostics, Inc. |
Rapid separation assay for total iron binding capacity
|
US6361749B1
(en)
|
1998-08-18 |
2002-03-26 |
Immunivest Corporation |
Apparatus and methods for magnetic separation
|
US6551843B1
(en)
|
1999-01-29 |
2003-04-22 |
Immunivest Corporation |
Methods for enhancing binding interactions between members of specific binding pairs
|
CN1399718A
(zh)
|
1999-04-09 |
2003-02-26 |
宇宙硬件最佳技术股份有限公司 |
用于纯化细胞、化学物质和蛋白质结构的多级电磁分离器
|
US20040058401A1
(en)
*
|
1999-04-13 |
2004-03-25 |
Blaise Bossy |
Method for detecting rare event
|
AU4682400A
(en)
*
|
1999-05-04 |
2000-11-17 |
Ortho-Clinical Diagnostics, Inc. |
Rapid and efficient capture of dna from sample without using cell lysing reagent
|
US6623982B1
(en)
*
|
1999-07-12 |
2003-09-23 |
Immunivest Corporation |
Increased separation efficiency via controlled aggregation of magnetic nanoparticles
|
US7022517B1
(en)
|
1999-07-16 |
2006-04-04 |
Board Of Regents, The University Of Texas System |
Method and apparatus for the delivery of samples to a chemical sensor array
|
ATE346287T1
(de)
|
1999-07-16 |
2006-12-15 |
Univ Texas |
Verfahren und vorrichtung zur zuführung von proben zu einer chemischen sensormatrix
|
US6713298B2
(en)
*
|
2000-01-31 |
2004-03-30 |
Board Of Regents, The University Of Texas System |
Method and apparatus for the delivery of samples to a chemical sensor array
|
US7262006B1
(en)
|
2000-05-01 |
2007-08-28 |
Ortho-Clinical Diagnostics, Inc. |
Rapid and efficient capture of DNA from sample without using cell lysing reagent
|
DE60117556T2
(de)
*
|
2000-06-21 |
2006-11-02 |
Bioarray Solutions Ltd. |
Multianalytische molekularanalyse durch verwendung anwendungsspezifischer zufallspartikelarrays
|
US9709559B2
(en)
|
2000-06-21 |
2017-07-18 |
Bioarray Solutions, Ltd. |
Multianalyte molecular analysis using application-specific random particle arrays
|
US7169618B2
(en)
|
2000-06-28 |
2007-01-30 |
Skold Technology |
Magnetic particles and methods of producing coated magnetic particles
|
WO2002016571A1
(fr)
*
|
2000-08-21 |
2002-02-28 |
National Institute Of Advanced Industrial Science And Technology |
Particules magnetiques ayant une temperature de solution critique de limite inferieure
|
GB2368909B
(en)
*
|
2000-11-09 |
2004-09-22 |
Amersham Pharm Biotech Uk Ltd |
Separation particles
|
US6649419B1
(en)
*
|
2000-11-28 |
2003-11-18 |
Large Scale Proteomics Corp. |
Method and apparatus for protein manipulation
|
US20020160363A1
(en)
*
|
2001-01-31 |
2002-10-31 |
Mcdevitt John T. |
Magnetic-based placement and retention of sensor elements in a sensor array
|
US20020197622A1
(en)
*
|
2001-01-31 |
2002-12-26 |
Mcdevitt John T. |
Method and apparatus for the confinement of materials in a micromachined chemical sensor array
|
WO2002063270A2
(en)
*
|
2001-02-05 |
2002-08-15 |
Board Of Regents, The University Of Texas System |
The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors
|
US7262063B2
(en)
|
2001-06-21 |
2007-08-28 |
Bio Array Solutions, Ltd. |
Directed assembly of functional heterostructures
|
FR2826592B1
(fr)
|
2001-06-27 |
2003-08-15 |
Bio Merieux |
Procede, dispositif, et equipement de separation par voie humide de micro particules magnetiques
|
US7863012B2
(en)
*
|
2004-02-17 |
2011-01-04 |
Veridex, Llc |
Analysis of circulating tumor cells, fragments, and debris
|
US20040106109A1
(en)
*
|
2001-10-02 |
2004-06-03 |
Belly Robert T |
Detection of ras mutations
|
EP2722395B1
(de)
|
2001-10-15 |
2018-12-19 |
Bioarray Solutions Ltd |
Gemultiplexte Analyse polymorphischer Stellen durch gleichzeitige Abfrage und enzymvermittelte Detektion
|
US7018849B2
(en)
*
|
2002-01-15 |
2006-03-28 |
Piasio Roger N |
Process for (A) separating biological/ligands from dilute solutions and (B) conducting an immunochromatographic assay thereof employing superparamagnetic particles throughtout
|
US6792019B2
(en)
*
|
2002-02-28 |
2004-09-14 |
Texas Instruments Incorporated |
Driver with tail currents in discrete subranges
|
US7214427B2
(en)
*
|
2002-03-21 |
2007-05-08 |
Aviva Biosciences Corporation |
Composite beads comprising magnetizable substance and electro-conductive substance
|
US7514270B2
(en)
*
|
2002-04-12 |
2009-04-07 |
Instrumentation Laboratory Company |
Immunoassay probe
|
CA2523626A1
(en)
|
2002-04-26 |
2003-11-06 |
Board Of Regents, The University Of Texas System |
Method and system for the detection of cardiac risk factors
|
AU2003299478A1
(en)
*
|
2002-05-07 |
2004-05-25 |
Regents Of The University Of California |
Bioactivation of particles
|
US20040229380A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
WO2004009840A1
(en)
*
|
2002-07-24 |
2004-01-29 |
Board Of Regents, The University Of Texas System |
Capture and detection of microbes by membrane methods
|
WO2004047007A1
(en)
|
2002-11-15 |
2004-06-03 |
Bioarray Solutions, Ltd. |
Analysis, secure access to, and transmission of array images
|
US20040109824A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Hinds Kathleen Allison |
Particles for imaging cells
|
US6964747B2
(en)
*
|
2003-01-21 |
2005-11-15 |
Bioarray Solutions, Ltd. |
Production of dyed polymer microparticles
|
US7255895B2
(en)
*
|
2003-01-21 |
2007-08-14 |
Bioarray Solutions, Ltd. |
Method for controlling solute loading of polymer microparticles
|
US6873241B1
(en)
|
2003-03-24 |
2005-03-29 |
Robert O. Sanchez |
High frequency transformers and high Q factor inductors formed using epoxy-based magnetic polymer materials
|
US7637920B2
(en)
|
2003-03-28 |
2009-12-29 |
Ev3 Inc. |
Double ended intravascular medical device
|
WO2004092353A2
(en)
|
2003-04-01 |
2004-10-28 |
Monogram Biosciences, Inc. |
Surface receptor complexes as biomarkers
|
US20050064452A1
(en)
*
|
2003-04-25 |
2005-03-24 |
Schmid Matthew J. |
System and method for the detection of analytes
|
WO2004104922A2
(en)
*
|
2003-05-16 |
2004-12-02 |
Board Of Regents, The University Of Texas System |
Image and part recognition technology
|
US9317922B2
(en)
|
2003-05-16 |
2016-04-19 |
Board Of Regents The University Of Texas System |
Image and part recognition technology
|
AR047692A1
(es)
*
|
2003-07-10 |
2006-02-08 |
Epix Medical Inc |
Imagenes de blancos estacionarios
|
US7402398B2
(en)
*
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
EP1654066B1
(de)
|
2003-07-31 |
2014-11-12 |
Handylab, Inc. |
Verarbeitung von teilchenhaltigen proben
|
WO2005019470A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
US7927796B2
(en)
*
|
2003-09-18 |
2011-04-19 |
Bioarray Solutions, Ltd. |
Number coding for identification of subtypes of coded types of solid phase carriers
|
NZ546072A
(en)
*
|
2003-09-22 |
2009-08-28 |
Bioarray Solutions Ltd |
Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
|
WO2005045059A2
(en)
*
|
2003-10-28 |
2005-05-19 |
Bioarray Solutions Ltd. |
Allele assignment and probe selection in multiplexed assays of polymorphic targets
|
WO2005042763A2
(en)
*
|
2003-10-28 |
2005-05-12 |
Bioarray Solutions Ltd. |
Optimization of gene expression analysis using immobilized capture probes
|
NZ547495A
(en)
|
2003-10-29 |
2008-05-30 |
Bioarray Solutions Ltd |
Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA
|
US7790473B2
(en)
*
|
2003-11-05 |
2010-09-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biofunctionalized quantum dots for biological imaging
|
US20050106577A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Hashem Akhavan-Tafti |
Cleavable solid phases for isolating nucleic acids
|
US20050106576A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Hashem Akhavan-Tafti |
Methods of using cleavable solid phases for isolating nucleic acids
|
AU2004237844B2
(en)
|
2003-12-23 |
2011-01-27 |
Therakos, Inc. |
Extracorporeal photopheresis in combination with anti-TNF treatment
|
US20050181353A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Rao Galla C. |
Stabilization of cells and biological specimens for analysis
|
US20060257991A1
(en)
*
|
2004-02-27 |
2006-11-16 |
Mcdevitt John T |
Integration of fluids and reagents into self-contained cartridges containing particle-based sensor elements and membrane-based sensor elements
|
US20060257854A1
(en)
*
|
2004-02-27 |
2006-11-16 |
Mcdevitt John T |
Membrane assay system including preloaded particles
|
US8101431B2
(en)
*
|
2004-02-27 |
2012-01-24 |
Board Of Regents, The University Of Texas System |
Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
|
US7781226B2
(en)
*
|
2004-02-27 |
2010-08-24 |
The Board Of Regents Of The University Of Texas System |
Particle on membrane assay system
|
US8105849B2
(en)
*
|
2004-02-27 |
2012-01-31 |
Board Of Regents, The University Of Texas System |
Integration of fluids and reagents into self-contained cartridges containing sensor elements
|
US8852862B2
(en)
|
2004-05-03 |
2014-10-07 |
Handylab, Inc. |
Method for processing polynucleotide-containing samples
|
US8211386B2
(en)
|
2004-06-08 |
2012-07-03 |
Biokit, S.A. |
Tapered cuvette and method of collecting magnetic particles
|
US7943396B2
(en)
*
|
2004-06-22 |
2011-05-17 |
The Regents Of The University Of California |
Peptide-coated nanoparticles with graded shell compositions
|
US7363170B2
(en)
*
|
2004-07-09 |
2008-04-22 |
Bio Array Solutions Ltd. |
Transfusion registry network providing real-time interaction between users and providers of genetically characterized blood products
|
US7848889B2
(en)
|
2004-08-02 |
2010-12-07 |
Bioarray Solutions, Ltd. |
Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
|
KR20070073935A
(ko)
|
2004-10-27 |
2007-07-10 |
세페이드 |
폐쇄 시스템의 다단계 핵산 증폭 반응
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
TWI277632B
(en)
*
|
2004-12-14 |
2007-04-01 |
Nat Univ Chung Cheng |
Magnetic polymer microbeads and a method for preparing the same
|
WO2006112771A1
(en)
*
|
2005-04-18 |
2006-10-26 |
Ge Healthcare Bio-Sciences Ab |
Magnetic beads
|
US7300631B2
(en)
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
US7611908B2
(en)
*
|
2005-05-02 |
2009-11-03 |
Bioscale, Inc. |
Method and apparatus for therapeutic drug monitoring using an acoustic device
|
US7749445B2
(en)
*
|
2005-05-02 |
2010-07-06 |
Bioscale, Inc. |
Method and apparatus for analyzing bioprocess fluids
|
US7648844B2
(en)
*
|
2005-05-02 |
2010-01-19 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using an acoustic device
|
WO2007053186A2
(en)
|
2005-05-31 |
2007-05-10 |
Labnow, Inc. |
Methods and compositions related to determination and use of white blood cell counts
|
US8486629B2
(en)
|
2005-06-01 |
2013-07-16 |
Bioarray Solutions, Ltd. |
Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
|
CN1700015B
(zh)
*
|
2005-06-20 |
2010-10-06 |
张爱华 |
组件式多功能传感器件
|
US20100291588A1
(en)
*
|
2005-06-24 |
2010-11-18 |
The Board Of Regents Of The University Of Texas System |
Systems and methods including self-contained cartridges with detection systems and fluid delivery systems
|
US20090215646A1
(en)
*
|
2005-07-01 |
2009-08-27 |
The Board Of Regents Of The University Of Texas Sy |
System and method of analyte detection using differential receptors
|
US7901950B2
(en)
*
|
2005-08-12 |
2011-03-08 |
Veridex, Llc |
Method for assessing disease states by profile analysis of isolated circulating endothelial cells
|
JP2009514530A
(ja)
|
2005-11-02 |
2009-04-09 |
セラコス・インコーポレイテッド |
生体外で制御性t細胞を生成するためのアポトーシス細胞の利用
|
DE102005058979A1
(de)
*
|
2005-12-09 |
2007-06-21 |
Qiagen Gmbh |
Magnetische Polymerpartikel
|
EP3088083B1
(de)
|
2006-03-24 |
2018-08-01 |
Handylab, Inc. |
Methode zur durchführung von pcr mittels einer kartusche mit mehreren bahnen
|
US11806718B2
(en)
|
2006-03-24 |
2023-11-07 |
Handylab, Inc. |
Fluorescence detector for microfluidic diagnostic system
|
US7998708B2
(en)
|
2006-03-24 |
2011-08-16 |
Handylab, Inc. |
Microfluidic system for amplifying and detecting polynucleotides in parallel
|
US8883490B2
(en)
|
2006-03-24 |
2014-11-11 |
Handylab, Inc. |
Fluorescence detector for microfluidic diagnostic system
|
US10900066B2
(en)
|
2006-03-24 |
2021-01-26 |
Handylab, Inc. |
Microfluidic system for amplifying and detecting polynucleotides in parallel
|
US8492097B2
(en)
*
|
2006-04-24 |
2013-07-23 |
Diagnostic Hybrids, Inc. |
Compositions and methods for human metapneumovirus monoclonal antibodies
|
KR101467136B1
(ko)
*
|
2006-06-02 |
2014-12-01 |
화이자 프로덕츠 인코포레이티드 |
순환 종양 세포 분석
|
WO2008028264A1
(en)
*
|
2006-09-05 |
2008-03-13 |
Centro Brasileiro De Pesquisas Fisicas-Cbpf |
Process for the production of micro-capsules having magnetic properties, product obtained therefrom and method for the controlled release of active substances
|
US20080300798A1
(en)
*
|
2007-04-16 |
2008-12-04 |
Mcdevitt John T |
Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
|
DK2152821T3
(da)
|
2007-06-05 |
2019-05-13 |
Bank Of Canada |
Trykfarve- eller tonersammensætninger, fremgangsmåder til anvendelse og produkter udledt derfra
|
US8182763B2
(en)
|
2007-07-13 |
2012-05-22 |
Handylab, Inc. |
Rack for sample tubes and reagent holders
|
US8287820B2
(en)
|
2007-07-13 |
2012-10-16 |
Handylab, Inc. |
Automated pipetting apparatus having a combined liquid pump and pipette head system
|
EP3741869A1
(de)
|
2007-07-13 |
2020-11-25 |
Handylab, Inc. |
Materialien zur erfassung von polynukleotiden und verfahren zur verwendung davon
|
US9186677B2
(en)
|
2007-07-13 |
2015-11-17 |
Handylab, Inc. |
Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
|
US8105783B2
(en)
|
2007-07-13 |
2012-01-31 |
Handylab, Inc. |
Microfluidic cartridge
|
WO2009033056A1
(en)
*
|
2007-09-06 |
2009-03-12 |
Bioscale, Inc. |
Reusable detection surfaces and methods of using same
|
ES2764077T3
(es)
|
2007-12-07 |
2020-06-02 |
Miltenyi Biotec Bv & Co Kg |
Sistemas y métodos para el procesamiento de muestras
|
US20110275985A1
(en)
*
|
2008-07-03 |
2011-11-10 |
T2 Biosystems, Inc. |
Magnetic nanosensor compositions and bioanalytical assays therefor
|
EP3181705A1
(de)
|
2008-11-12 |
2017-06-21 |
Caris Life Sciences Switzerland Holdings GmbH |
Verfahren und systeme zur verwendung von exosomen zur bestimmung von phänotypen
|
US8710836B2
(en)
*
|
2008-12-10 |
2014-04-29 |
Nanomr, Inc. |
NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
|
EP2230515B1
(de)
|
2009-03-16 |
2014-12-17 |
Agilent Technologies, Inc. |
Passivierung von Oberflächen nach Ligandenkupplung
|
US8790916B2
(en)
*
|
2009-05-14 |
2014-07-29 |
Genestream, Inc. |
Microfluidic method and system for isolating particles from biological fluid
|
JP5270486B2
(ja)
*
|
2009-07-31 |
2013-08-21 |
トヨタ自動車株式会社 |
ナノ物質集積体の製造方法、ナノ物質集積体およびそれを用いたデバイス、ならびにナノ物質の構造解析方法
|
CA2787027A1
(en)
|
2010-01-13 |
2011-07-21 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Detection of gastrointestinal disorders
|
CN103237901B
(zh)
|
2010-03-01 |
2016-08-03 |
卡里斯生命科学瑞士控股有限责任公司 |
用于治疗诊断的生物标志物
|
US9469876B2
(en)
|
2010-04-06 |
2016-10-18 |
Caris Life Sciences Switzerland Holdings Gmbh |
Circulating biomarkers for metastatic prostate cancer
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US9428547B2
(en)
|
2010-04-21 |
2016-08-30 |
Dna Electronics, Inc. |
Compositions for isolating a target analyte from a heterogeneous sample
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
US20120094275A1
(en)
|
2010-10-14 |
2012-04-19 |
Galla Chandra Rao |
Methods and kits for the detection of circulating tumor cells in pancreatic patients using polyspecific capture and cocktail detection reagents
|
EP3159697B1
(de)
|
2011-04-15 |
2019-12-25 |
Becton, Dickinson and Company |
Mikrofluidischer echtzeit-abtastender thermocycler
|
DE102011050550A1
(de)
*
|
2011-05-20 |
2012-11-22 |
Wolfgang Göhde |
Verfahren und Anordnung zur Quantifizierung von Untergruppen aus einer Mischpopulation von Zellen
|
TW201311907A
(zh)
|
2011-07-07 |
2013-03-16 |
Veridex Llc |
使用循環內皮細胞的基因診斷
|
US20130095038A1
(en)
*
|
2011-10-15 |
2013-04-18 |
Canon Kabushiki Kaisha |
Particles, and photoacoustic imaging contrast agent and sln contrast agent including the particles
|
CN104040238B
(zh)
|
2011-11-04 |
2017-06-27 |
汉迪拉布公司 |
多核苷酸样品制备装置
|
BR112014015424A2
(pt)
|
2011-12-23 |
2018-05-22 |
Depuy Synthes Products Llc |
detecção de células derivadas de tecido do cordão umbilical humano
|
WO2013106948A1
(zh)
|
2012-01-18 |
2013-07-25 |
芮宝生医股份有限公司 |
磁性微粒复合物的制作方法
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
AU2013340414B2
(en)
|
2012-10-23 |
2019-05-02 |
Caris Science, Inc. |
Aptamers and uses thereof
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
WO2014100434A1
(en)
|
2012-12-19 |
2014-06-26 |
Caris Science, Inc. |
Compositions and methods for aptamer screening
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
RU2507155C1
(ru)
*
|
2012-12-28 |
2014-02-20 |
Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Национальный исследовательский технологический университет "МИСиС" |
Способ получения наночастиц магнетита, стабилизированных поливиниловым спиртом
|
BR112016004153A2
(pt)
|
2013-08-28 |
2019-09-17 |
Caris Life Sciences Switzerland Holdings Gmbh |
"método para caracterizar uma doença ou distúrbio, kit, composição, método para gerar uma biblioteca de entrada, oligonucleotídeo, pluralidade de oligonucleotídeos e método para identificar um aptâmero
|
US10656147B2
(en)
*
|
2014-02-28 |
2020-05-19 |
Dh Technologies Development Pte. Ltd. |
Magnetic elements for processing fluids
|
EP4219687A1
(de)
|
2014-04-23 |
2023-08-02 |
Juno Therapeutics, Inc. |
Verfahren zur isolierung, kultivierung und genetischen manipulation von immunzellpopulationen für die adoptive therapie
|
CA2954414A1
(en)
|
2014-07-15 |
2016-01-21 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
WO2016064929A1
(en)
|
2014-10-20 |
2016-04-28 |
Juno Therapeutics, Inc. |
Methods and compositions for dosing in adoptive cell therapy
|
IL292450A
(en)
|
2014-11-05 |
2022-06-01 |
Juno Therapeutics Inc |
Transduction methods and cellular processing
|
WO2016090190A1
(en)
|
2014-12-03 |
2016-06-09 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
EP3760644A1
(de)
|
2015-01-16 |
2021-01-06 |
Juno Therapeutics, Inc. |
Antikörper und chimäre, für ror1 spezifische antigenrezeptoren
|
DE102015101834A1
(de)
|
2015-02-09 |
2016-08-11 |
Technische Universität Ilmenau |
Verfahren und Vorrichtung zur Detektion und Lokalisierung von mikrostimulierten Partikeln
|
CA2979361A1
(en)
|
2015-03-09 |
2016-09-15 |
Caris Science, Inc. |
Method of preparing oligonucleotide libraries
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
EP3288912A4
(de)
|
2015-05-01 |
2018-11-07 |
Biolegend, Inc. |
Stabile nanomagnetische partikeldispersionen
|
CN108174607A
(zh)
|
2015-05-29 |
2018-06-15 |
朱诺治疗学股份有限公司 |
用于遗传工程改造的细胞中调节抑制性相互作用的组合物和方法
|
AU2016287499B2
(en)
|
2015-06-29 |
2022-08-04 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
MA42895A
(fr)
|
2015-07-15 |
2018-05-23 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
EP3328873A4
(de)
|
2015-07-28 |
2019-04-10 |
Caris Science, Inc. |
Gezielte oligonukleotide
|
EP3347485B1
(de)
|
2015-09-11 |
2021-11-03 |
Bacteria Detection Ltd |
Verfahren zur isolierung mikrobieller zellen aus einer blutprobe
|
MX2018004871A
(es)
|
2015-10-22 |
2018-11-09 |
Juno Therapeutics Gmbh |
Metodos, kits, agentes y aparatos para transduccion.
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
US11020429B2
(en)
|
2015-11-05 |
2021-06-01 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
MA44314A
(fr)
|
2015-11-05 |
2018-09-12 |
Juno Therapeutics Inc |
Récepteurs chimériques contenant des domaines induisant traf, et compositions et méthodes associées
|
MA43378A
(fr)
|
2015-12-03 |
2018-10-10 |
Juno Therapeutics Inc |
Compositions et méthodes pour la reduction de la réponse immunitaire contre récepteurs d'antigène chimériques
|
MX2018006789A
(es)
|
2015-12-03 |
2019-02-13 |
Juno Therapeutics Inc |
Receptores quimericos modificados y composiciones y metodos relacionados.
|
MA43377A
(fr)
|
2015-12-04 |
2021-05-19 |
Hutchinson Fred Cancer Res |
Méthodes et compositions liées à la toxicité associée à la thérapie cellulaire
|
SG11201804957VA
(en)
|
2015-12-16 |
2018-07-30 |
Gritstone Oncology Inc |
Neoantigen identification, manufacture, and use
|
MA43758A
(fr)
|
2016-03-16 |
2018-11-28 |
Yuan Ji |
Procédés pour déterminer le dosage d'un agent thérapeutique et traitements associés
|
EP3430549A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zum adaptiven design eines behandlungsplans und ähnlicher behandlungen
|
AU2017235661B2
(en)
|
2016-03-18 |
2023-06-08 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
AU2017238218A1
(en)
|
2016-03-22 |
2018-10-11 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Early intervention methods to prevent or ameliorate toxicity
|
US20190127697A1
(en)
|
2016-04-30 |
2019-05-02 |
BioLegend, Inc. |
Compositions and methods for performing magnetibuoyant separations
|
IL298701B2
(en)
|
2016-05-25 |
2024-03-01 |
Caris Science Inc |
Oligonucleotide probes and their uses
|
CA3026453A1
(en)
|
2016-06-03 |
2017-12-07 |
Memorial Sloan-Kettering Cancer Center |
Adoptive cell therapies as early treatment options
|
MA45341A
(fr)
|
2016-06-06 |
2019-04-10 |
Hutchinson Fred Cancer Res |
Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
|
MA45455A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Procédé d'identification d'épitopes peptidiques, molécules qui se lient à de tels épitopes et utilisations associées
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
BR112019001327A2
(pt)
|
2016-07-29 |
2019-04-30 |
Juno Therapeutics Inc |
anticorpos anti-idiotípicos e métodos relacionados
|
ES2926513T3
(es)
|
2016-07-29 |
2022-10-26 |
Juno Therapeutics Inc |
Métodos para evaluar la presencia o ausencia de virus competente en replicación
|
MA45779A
(fr)
|
2016-07-29 |
2019-06-05 |
Juno Therapeutics Inc |
Polypeptides immunomdulateurs et compositions et procédés associés
|
EP3957997A1
(de)
|
2016-08-26 |
2022-02-23 |
Juno Therapeutics, Inc. |
Verfahren zur zählung von partikeln in einer zellzusammensetzung
|
BR112019004662A2
(pt)
|
2016-09-12 |
2019-05-28 |
Juno Therapeutics Inc |
conjuntos de sacos de biorreator de perfusão
|
KR20190062505A
(ko)
|
2016-10-03 |
2019-06-05 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Hpv-특이적 결합 분자
|
MX2019004181A
(es)
|
2016-10-13 |
2019-10-30 |
Juno Therapeutics Inc |
Métodos y composiciones de inmunoterapia que implican moduladores de la ruta metabólica de triptófano.
|
US20190298772A1
(en)
|
2016-11-03 |
2019-10-03 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell-based therapy and a btk inhibitor
|
EP3534940A1
(de)
|
2016-11-03 |
2019-09-11 |
Juno Therapeutics, Inc. |
Kombinationstherapie aus einer zellbasierten therapie und einem mikrogliahemmer
|
CN110494565A
(zh)
|
2016-12-02 |
2019-11-22 |
朱诺治疗学股份有限公司 |
工程化b细胞及相关组合物和方法
|
CA3045508A1
(en)
|
2016-12-03 |
2018-06-07 |
Juno Therapeutics, Inc. |
Methods for modulation of car-t cells
|
BR112019011065A2
(pt)
|
2016-12-03 |
2019-10-01 |
Juno Therapeutics Inc |
métodos para determinação da dosagem de células t car
|
US11590167B2
(en)
|
2016-12-03 |
2023-02-28 |
Juno Therapeutic, Inc. |
Methods and compositions for use of therapeutic T cells in combination with kinase inhibitors
|
CA3045338A1
(en)
|
2016-12-05 |
2018-06-14 |
Juno Therapeutics, Inc. |
Production of engineered cells for adoptive cell therapy
|
CA3049461A1
(en)
|
2017-01-10 |
2018-07-19 |
Juno Therapeutics, Inc. |
Epigenetic analysis of cell therapy and related methods
|
CN110418802A
(zh)
|
2017-01-20 |
2019-11-05 |
朱诺治疗学有限公司 |
细胞表面缀合物及相关的细胞组合物和方法
|
CN110461335A
(zh)
|
2017-02-17 |
2019-11-15 |
弗雷德哈钦森癌症研究中心 |
用于治疗bcma相关癌症和自身免疫性失调的联合疗法
|
AU2018224856A1
(en)
|
2017-02-27 |
2019-08-29 |
Juno Therapeutics, Inc. |
Compositions, articles of manufacture and methods related to dosing in cell therapy
|
SG11201908271WA
(en)
|
2017-03-14 |
2019-10-30 |
Juno Therapeutics Inc |
Methods for cryogenic storage
|
AU2018250336A1
(en)
|
2017-04-07 |
2019-09-26 |
Juno Therapeutics, Inc. |
Engineered cells expressing prostate-specific membrane antigen (PSMA) or a modified form thereof and related methods
|
AU2018251188A1
(en)
|
2017-04-14 |
2019-10-31 |
Juno Therapeutics, Inc. |
Methods for assessing cell surface glycosylation
|
JP7339160B2
(ja)
|
2017-04-27 |
2023-09-05 |
ジュノ セラピューティクス ゲーエムベーハー |
オリゴマー粒子試薬およびその使用方法
|
CA3061945A1
(en)
|
2017-05-01 |
2018-11-08 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and an immunomodulatory compound
|
AU2018275894A1
(en)
|
2017-06-02 |
2019-12-12 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
MA48781A
(fr)
|
2017-06-02 |
2020-04-08 |
Juno Therapeutics Inc |
Articles de fabrication et procédés liés à la toxicité associée à la thérapie cellulaire
|
US20220225597A1
(en)
|
2017-06-29 |
2022-07-21 |
Juno Therapeutics, Inc. |
Mouse model for assessing toxicities associated with immunotherapies
|
US20230242654A1
(en)
|
2017-07-29 |
2023-08-03 |
Juno Therapeutics, Inc. |
Reagents for expanding cells expressing recombinant receptors
|
JP2020530294A
(ja)
|
2017-08-09 |
2020-10-22 |
ジュノー セラピューティクス インコーポレイテッド |
遺伝子操作された細胞を調製するための方法および組成物
|
BR112020001605A2
(pt)
|
2017-08-09 |
2020-08-11 |
Juno Therapeutics Inc |
métodos para produzir composições de células geneticamente modificadas e composições relacionadas
|
WO2019046832A1
(en)
|
2017-09-01 |
2019-03-07 |
Juno Therapeutics, Inc. |
GENE EXPRESSION AND EVALUATION OF RISK OF DEVELOPMENT OF TOXICITY FOLLOWING CELL THERAPY
|
EP3679370A1
(de)
|
2017-09-07 |
2020-07-15 |
Juno Therapeutics, Inc. |
Verfahren zur identifizierung von zellulären attributen im zusammenhang mit den ergebnissen einer zelltherapie
|
JP2020537515A
(ja)
|
2017-10-03 |
2020-12-24 |
ジュノー セラピューティクス インコーポレイテッド |
Hpv特異的結合分子
|
EP3694532A4
(de)
|
2017-10-10 |
2021-07-14 |
Gritstone Oncology, Inc. |
Neoantigen-identifizierung mittels hotspots
|
SG11202003501XA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
SG11202003657VA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Process for producing a t cell composition
|
SG11202003866QA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Chimeric antigen receptors specific for b-cell maturation antigen (bcma)
|
SG11202003688PA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Process for generating therapeutic compositions of engineered cells
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
US11564946B2
(en)
|
2017-11-01 |
2023-01-31 |
Juno Therapeutics, Inc. |
Methods associated with tumor burden for assessing response to a cell therapy
|
CN111886012A
(zh)
|
2017-11-06 |
2020-11-03 |
朱诺治疗学股份有限公司 |
细胞疗法与γ分泌酶抑制剂的组合
|
JP2021502094A
(ja)
|
2017-11-10 |
2021-01-28 |
ジュノー セラピューティクス インコーポレイテッド |
閉鎖系極低温容器
|
US11885815B2
(en)
|
2017-11-22 |
2024-01-30 |
Gritstone Bio, Inc. |
Reducing junction epitope presentation for neoantigens
|
WO2019109053A1
(en)
|
2017-12-01 |
2019-06-06 |
Juno Therapeutics, Inc. |
Methods for dosing and for modulation of genetically engineered cells
|
KR20200109308A
(ko)
|
2017-12-08 |
2020-09-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
세포 요법을 위한 표현형 마커 및 관련 방법
|
WO2019113556A1
(en)
|
2017-12-08 |
2019-06-13 |
Juno Therapeutics, Inc. |
Serum-free media formulation for culturing cells and methods of use thereof
|
CA3084445A1
(en)
|
2017-12-08 |
2019-06-13 |
Juno Therapeutics, Inc. |
Process for producing a composition of engineered t cells
|
CN112204048A
(zh)
|
2017-12-15 |
2021-01-08 |
朱诺治疗学股份有限公司 |
抗cct5结合分子及其使用方法
|
JP2021511802A
(ja)
|
2018-01-31 |
2021-05-13 |
ジュノー セラピューティクス インコーポレイテッド |
複製可能ウイルスの存在または非存在を評価するための方法および試薬
|
MA54118A
(fr)
|
2018-01-31 |
2021-09-15 |
Celgene Corp |
Polythérapie utilisant une thérapie cellulaire adoptive et un inhibiteur de point de contrôle
|
JP7335883B2
(ja)
|
2018-02-28 |
2023-08-30 |
ジュノー セラピューティクス インコーポレイテッド |
細胞組成物中に存在する粒子を検出するための方法
|
EP3762012A1
(de)
|
2018-03-09 |
2021-01-13 |
Ospedale San Raffaele S.r.l. |
Il-1-antagonist und durch zelltherapie induzierte toxizität
|
EP3773908A1
(de)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
T-zell-rezeptoren und gentechnisch veränderte zellen zur expression davon
|
MA52656A
(fr)
|
2018-04-05 |
2021-02-17 |
Editas Medicine Inc |
Procédés de production de cellules exprimant un récepteur recombinant et compositions associées
|
EP3775237A1
(de)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
T-zellen, die einen rekombinanten rezeptor exprimieren, verwandte polynukleotide und verfahren
|
WO2019213184A1
(en)
|
2018-05-03 |
2019-11-07 |
Juno Therapeutics, Inc. |
Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
|
WO2019216887A1
(en)
|
2018-05-08 |
2019-11-14 |
Biomagnetic Solutions Llc |
A rigid chamber for cell separation from a flexible disposable bag
|
JP2021528101A
(ja)
|
2018-06-13 |
2021-10-21 |
アクロン バイオテクノロジー,エルエルシー. |
液体医薬組成物中で非常に安定な治療的に活性なアルデスロイキンを調製する方法
|
AU2019318560A1
(en)
|
2018-08-09 |
2021-02-25 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
EA202190469A1
(ru)
|
2018-08-09 |
2021-06-28 |
Джуно Терапьютикс, Инк. |
Способы оценки интегрированных нуклеиновых кислот
|
EP3843778A1
(de)
|
2018-08-31 |
2021-07-07 |
Invectys Sa |
Chimäre antigenrezeptoren gegen mehrere hla-g-isoformen
|
SG11202102108QA
(en)
|
2018-09-11 |
2021-04-29 |
Juno Therapeutics Inc |
Methods for mass spectrometry analysis of engineered cell compositions
|
US20210393689A1
(en)
|
2018-11-01 |
2021-12-23 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)
|
US20210393690A1
(en)
|
2018-11-01 |
2021-12-23 |
Juno Therapeutics, Inc. |
Methods for treatment using chimeric antigen receptors specific for b-cell maturation antigen
|
EP3877054B1
(de)
|
2018-11-06 |
2023-11-01 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von genetisch veränderten t-zellen
|
CA3117978A1
(en)
|
2018-11-08 |
2020-05-14 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and t cell modulation
|
AU2019381827A1
(en)
|
2018-11-16 |
2021-06-10 |
Juno Therapeutics, Inc. |
Methods of dosing engineered T cells for the treatment of B cell malignancies
|
EP3886894B1
(de)
|
2018-11-30 |
2024-03-13 |
Juno Therapeutics, Inc. |
Verfahren zur dosierung und behandlung von b-zell-malignomen in der adoptiven zelltherapie
|
SG11202105502RA
(en)
|
2018-11-30 |
2021-06-29 |
Juno Therapeutics Inc |
Methods for treatment using adoptive cell therapy
|
EP3917570A1
(de)
|
2019-01-29 |
2021-12-08 |
Juno Therapeutics, Inc. |
Antikörper und chimäre antigen-rezeptoren spezifisch für rezeptortyrosinkinase-like orphanrezeptor 1 (ror1)
|
JP2022531577A
(ja)
|
2019-05-01 |
2022-07-07 |
ジュノー セラピューティクス インコーポレイテッド |
改変されたcd247遺伝子座からキメラ受容体を発現する細胞、関連ポリヌクレオチド、および方法
|
WO2020223535A1
(en)
|
2019-05-01 |
2020-11-05 |
Juno Therapeutics, Inc. |
Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methods
|
WO2020252218A1
(en)
|
2019-06-12 |
2020-12-17 |
Juno Therapeutics, Inc. |
Combination therapy of a cell-mediated cytotoxic therapy and an inhibitor of a prosurvival bcl2 family protein
|
WO2021035194A1
(en)
|
2019-08-22 |
2021-02-25 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods
|
US20220392613A1
(en)
|
2019-08-30 |
2022-12-08 |
Juno Therapeutics, Inc. |
Machine learning methods for classifying cells
|
EP4055383A1
(de)
|
2019-11-05 |
2022-09-14 |
Juno Therapeutics, Inc. |
Verfahren zur bestimmung von eigenschaften therapeutischer t-zellzusammensetzungen
|
US20220401483A1
(en)
|
2019-11-07 |
2022-12-22 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and (s)-3-[4-(4-morpholin-4-ylmethyl-benzyloxy)-l-oxo-l,3-dihydro-isoindol-2-yl]-piperidine-2,6-dione
|
US20230053787A1
(en)
|
2019-12-06 |
2023-02-23 |
Juno Therapeutics, Inc. |
Methods related to toxicity and response associated with cell therapy for treating b cell malignancies
|
JP2023504740A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
WO2021113780A1
(en)
|
2019-12-06 |
2021-06-10 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods
|
EP4093433A1
(de)
|
2020-01-24 |
2022-11-30 |
Juno Therapeutics, Inc. |
Verfahren zum dosieren und zur behandlung von follikulären lymphomen und rangenzonen-lymphomen im rahmen der adaptiven zelltherapie
|
EP4097218A1
(de)
|
2020-01-28 |
2022-12-07 |
Juno Therapeutics, Inc. |
Verfahren für t-zell-transduktion
|
JP2023519099A
(ja)
|
2020-02-12 |
2023-05-10 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用
|
AU2021220875A1
(en)
|
2020-02-12 |
2022-09-29 |
Juno Therapeutics, Inc. |
CD19-directed chimeric antigen receptor T cell compositions and methods and uses thereof
|
CA3179800A1
(en)
|
2020-04-10 |
2021-10-14 |
Juno Therapeutics, Inc. |
Methods and uses related to cell therapy engineered with a chimeric antigen receptor targeting b-cell maturation antigen
|
US20230165872A1
(en)
|
2020-04-28 |
2023-06-01 |
Juno Therapeutics, Inc. |
Combination of bcma-directed t cell therapy and an immunomodulatory compound
|
US20230181641A1
(en)
|
2020-05-13 |
2023-06-15 |
Juno Therapeutics, Inc. |
Process for producing donor-batched cells expressing a recombinant receptor
|
US20230178239A1
(en)
|
2020-05-13 |
2023-06-08 |
Juno Therapeutics, Inc. |
Methods of identifying features associated with clinical response and uses thereof
|
CN116234558A
(zh)
|
2020-06-26 |
2023-06-06 |
朱诺治疗学有限公司 |
条件性地表达重组受体的工程化t细胞、相关多核苷酸和方法
|
JP2023536326A
(ja)
|
2020-08-05 |
2023-08-24 |
ジュノー セラピューティクス インコーポレイテッド |
Ror1標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
JP2023549780A
(ja)
|
2020-11-04 |
2023-11-29 |
ジュノー セラピューティクス インコーポレイテッド |
改変されたインバリアントcd3免疫グロブリンスーパーファミリー鎖遺伝子座からキメラ受容体を発現する細胞ならびに関連するポリヌクレオチドおよび方法
|
WO2022133030A1
(en)
|
2020-12-16 |
2022-06-23 |
Juno Therapeutics, Inc. |
Combination therapy of a cell therapy and a bcl2 inhibitor
|
KR20230165771A
(ko)
|
2021-03-03 |
2023-12-05 |
주노 쎄러퓨티크스 인코퍼레이티드 |
T 세포 요법 및 dgk 억제제의 조합
|
WO2022204070A1
(en)
|
2021-03-22 |
2022-09-29 |
Juno Therapeutics, Inc. |
Methods of determining potency of a therapeutic cell composition
|
AU2022252220A1
(en)
|
2021-03-29 |
2023-10-12 |
Juno Therapeutics, Inc. |
Combination of a car t cell therapy and an immunomodulatory compound for treatment of lymphoma
|
EP4313127A1
(de)
|
2021-03-29 |
2024-02-07 |
Juno Therapeutics, Inc. |
Verfahren zur dosierung und behandlung mit einer kombination aus einer checkpoint-inhibitor-therapie und einer car-t-zelltherapie
|
CA3214683A1
(en)
|
2021-04-16 |
2022-10-20 |
Julie Ann RYTLEWSKI |
Combination therapies with bcma-directed t cell therapy
|
CN113281500B
(zh)
*
|
2021-05-21 |
2022-07-12 |
深圳市光与生物科技有限公司 |
一种用于单分子检测的磁珠及其制备方法
|
WO2023081735A1
(en)
|
2021-11-03 |
2023-05-11 |
Celgene Corporation |
Chimeric antigen receptors specific for b-cell maturation antigen for use in treating myeloma
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023147515A1
(en)
|
2022-01-28 |
2023-08-03 |
Juno Therapeutics, Inc. |
Methods of manufacturing cellular compositions
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
WO2023230548A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Method for predicting response to a t cell therapy
|
WO2023250400A1
(en)
|
2022-06-22 |
2023-12-28 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
WO2024006960A1
(en)
|
2022-06-29 |
2024-01-04 |
Juno Therapeutics, Inc. |
Lipid nanoparticles for delivery of nucleic acids
|
WO2024031091A2
(en)
|
2022-08-05 |
2024-02-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for gprc5d and bcma
|
WO2024044779A2
(en)
|
2022-08-26 |
2024-02-29 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3)
|